Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Twist Bioscience Corp
(NQ:
TWST
)
53.00
+0.17 (+0.32%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jun 6, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Twist Bioscience Corp
< Previous
1
2
3
4
5
6
7
8
Next >
Twist Bioscience and IMIDomics Collaborate to Discover Antibodies for Applications in Immune-Mediated Inflammatory Diseases
September 27, 2023
From
Twist Bioscience Corporation
Via
Business Wire
Twist Bioscience to Present at Upcoming Investor Conferences
September 05, 2023
From
Twist Bioscience Corporation
Via
Business Wire
Twist Bioscience Enters into Agreement with Ono Pharmaceutical to Discover Novel Antibodies for Autoimmune Diseases
August 31, 2023
From
Twist Bioscience Corporation
Via
Business Wire
Twist Bioscience Releases 2023 ESG Report and Quantifies Carbon Footprint of Manufacturing a Single Gene
August 22, 2023
From
Twist Bioscience Corporation
Via
Business Wire
Twist Bioscience to Present at the UBS MedTech, Tools and Genomics Summit 2023
August 07, 2023
From
Twist Bioscience Corporation
Via
Business Wire
Twist Bioscience Reports Fiscal Third Quarter 2023 Financial Results
August 04, 2023
From
Twist Bioscience Corporation
Via
Business Wire
Twist Bioscience to Report Fiscal 2023 Third Quarter Financial Results on Friday, August 4, 2023
July 20, 2023
From
Twist Bioscience Corporation
Via
Business Wire
Twist Bioscience and Cancer Research Horizons Enter into Collaboration to Advance Cancer Research
July 18, 2023
From
Twist Bioscience Corporation
Via
Business Wire
Twist Bioscience Publishes Preclinical Data in Diabetes Validating GLP-1R Antagonist Antibody as Potential Treatment for Congenital Hyperinsulinism
June 26, 2023
From
Twist Bioscience Corporation
Via
Business Wire
Twist Bioscience Appoints Chet Gandhi as Chief Information Officer
June 20, 2023
From
Twist Bioscience Corporation
Via
Business Wire
Twist Bioscience and CeGaT Launch RNA Fusion Panel to Advance Oncology and Precision Medicine Research
May 31, 2023
From
Twist Bioscience Corporation
Via
Business Wire
Twist Bioscience to Present at Upcoming Investor Conferences
May 24, 2023
From
Twist Bioscience Corporation
Via
Business Wire
Twist Bioscience Appoints Robert Werner as Chief Accounting Officer
May 23, 2023
From
Twist Bioscience Corporation
Via
Business Wire
Twist Bioscience Launches Portfolio of RNA Sequencing Tools
May 22, 2023
From
Twist Bioscience Corporation
Via
Business Wire
Twist Bioscience to Present at ITF World 2023
May 10, 2023
From
Twist Bioscience Corporation
Via
Business Wire
Twist Bioscience Reports Fiscal Second Quarter 2023 Financial Results
May 05, 2023
From
Twist Bioscience Corporation
Via
Business Wire
Twist Bioscience and Aster Insights Partner on Launch of Next Generation Oncology Panel for Cancer Research
April 27, 2023
From
Twist Bioscience Corporation
Via
Business Wire
Twist Bioscience Enters into Third Collaboration with Astellas to Support Antibody Discovery for Immunotherapies
April 20, 2023
From
Twist Bioscience Corporation
Via
Business Wire
Twist Bioscience Launches TCR and CAR Libraries to Enable the Development of Cell Therapies
April 13, 2023
From
Twist Bioscience Corporation
Via
Business Wire
Twist Bioscience to Report Fiscal 2023 Second Quarter Financial Results on Friday, May 5, 2023
April 13, 2023
From
Twist Bioscience Corporation
Via
Business Wire
TWIST ALERT: Bragar Eagel & Squire, P.C. is Investigating Twist Bioscience Corp on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
March 16, 2023
From
Bragar Eagel & Squire, P.C.
Via
Business Wire
DNA Data Storage Alliance Announces Board Appointments
March 29, 2023
From
DNA Data Storage Alliance
Via
Business Wire
NASDAQ:TWST Long Term Investor Alert: Investigation of Potential Wrongdoing at Twist Bioscience Corporation
March 15, 2023
San Diego, CA -- (SBWIRE) -- 03/15/2023 -- An investigation was announced for current long-term investors in shares of Twist Bioscience Corporation (NASDAQ:TWST) concerning potential breaches of...
Via
SBWire
Twist Bioscience Announces Robust Antibody Discovery Services Integrating In Vivo, In Vitro and In Silico Approaches
March 09, 2023
From
Twist Bioscience Corporation
Via
Business Wire
Twist Bioscience to Present at Upcoming Investor Conferences
February 28, 2023
From
Twist Bioscience Corporation
Via
Business Wire
Twist Bioscience Publishes Data on VHH Single Domain Antibody Discovery Using New Methodology on Optofluidic Platform
February 14, 2023
From
Twist Bioscience Corporation
Via
Business Wire
TWST FINAL DEADLINE TODAY: ROSEN, NATIONAL TRIAL LAWYERS, Encourages Twist Bioscience Corporation Investors to Secure Counsel Before Important February 10 Deadline in Securities Class Action – TWST
February 10, 2023
From
Rosen Law Firm
Via
Business Wire
Deadline Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Twist Bioscience Corporation (TWST) Investors of Class Action and to Actively Participate
February 10, 2023
From
Bronstein, Gewirtz & Grossman, LLC
Via
Business Wire
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Twist Bioscience Corporation (TWST)
February 09, 2023
From
The Law Offices of Frank R. Cruz
Via
Business Wire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Iris, Twist, Sunlight and Gaia and Encourages Investors to Contact the Firm
February 08, 2023
From
Bragar Eagel & Squire
Via
GlobeNewswire
< Previous
1
2
3
4
5
6
7
8
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.